APA (7th ed.) Citation

Imada, T., Sasaki, S., Yamaguchi, H., Ueda, A., Kawamori, D., Katakami, N., & Shimomura, I. (2025). Imeglimin, unlike metformin, does not perturb differentiation of human induced pluripotent stem cells towards pancreatic β‐like cells and rather enhances gain in β cell identity gene sets. Journal of Diabetes Investigation, 16(4), 584. https://doi.org/10.1111/jdi.14410

Chicago Style (17th ed.) Citation

Imada, Tasuku, Shugo Sasaki, Hiroki Yamaguchi, Ayaka Ueda, Dan Kawamori, Naoto Katakami, and Iichiro Shimomura. "Imeglimin, Unlike Metformin, Does Not Perturb Differentiation of Human Induced Pluripotent Stem Cells Towards Pancreatic β‐like Cells and Rather Enhances Gain in β Cell Identity Gene Sets." Journal of Diabetes Investigation 16, no. 4 (2025): 584. https://doi.org/10.1111/jdi.14410.

MLA (9th ed.) Citation

Imada, Tasuku, et al. "Imeglimin, Unlike Metformin, Does Not Perturb Differentiation of Human Induced Pluripotent Stem Cells Towards Pancreatic β‐like Cells and Rather Enhances Gain in β Cell Identity Gene Sets." Journal of Diabetes Investigation, vol. 16, no. 4, 2025, p. 584, https://doi.org/10.1111/jdi.14410.